Overview

Inhaled Nitric Oxide for Cardiac Arrest in Pediatrics and Adults (iNOCAPA)

Status:
Recruiting
Trial end date:
2026-01-31
Target enrollment:
Participant gender:
Summary
This study is a multi-center, double blind, randomized controlled trial of inhaled nitric oxide (iNO) in children and adults with cardiac arrest (CA). The purpose of this pilot study is to test the feasibility of rapidly randomizing patients to iNO or sham treatment during cardiopulmonary resuscitation (CPR) or shortly after return of circulation (ROC) and evaluate blood biomarkers associated with iNO compared to sham. Return of circulation may refer to return of spontaneous circulation (ROSC) or ROC through extracorporeal cardiopulmonary resuscitation (E-CPR).
Phase:
Phase 2
Details
Lead Sponsor:
The Hospital for Sick Children
Collaborator:
Heart and Stroke Foundation of Canada
Treatments:
Nitric Oxide